Skip to main content
. 2022 Feb 5;380(2):10. doi: 10.1007/s41061-022-00365-x

Fig. 9.

Fig. 9

SAR evaluation of 3,6,7-trisubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines as anticancer agents